Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Net Income (2016 - 2026)

Tenax Therapeutics' Net Income history spans 7 years, with the latest figure at -$17.0 million for Q4 2017.

  • On a quarterly basis, Net Income rose 74.78% to -$17.0 million in Q4 2017 year-over-year; TTM through Dec 2017 was -$9.2 million, a 85.63% increase, with the full-year FY2025 number at -$52.6 million, down 198.62% from a year prior.
  • Net Income hit -$17.0 million in Q4 2017 for Tenax Therapeutics, down from $1.3 million in the prior quarter.
  • Over the last five years, Net Income for TENX hit a ceiling of $4.7 million in Q2 2016 and a floor of -$67.5 million in Q4 2016.
  • Historically, Net Income has averaged -$7.4 million across 4 years, with a median of -$2.4 million in 2013.
  • The widest YoY moves for Net Income: up 244.99% in 2016, down 547.62% in 2016.
  • Tracing TENX's Net Income over 4 years: stood at -$1.9 million in 2013, then crashed by 459.84% to -$10.4 million in 2015, then tumbled by 547.62% to -$67.5 million in 2016, then soared by 74.78% to -$17.0 million in 2017.
  • Business Quant data shows Net Income for TENX at -$17.0 million in Q4 2017, $1.3 million in Q3 2017, and $3.0 million in Q2 2017.